These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

300 related items for PubMed ID: 16460953

  • 1. Mining the NCI antiviral compounds for HIV-1 integrase inhibitors.
    Deng J, Kelley JA, Barchi JJ, Sanchez T, Dayam R, Pommier Y, Neamati N.
    Bioorg Med Chem; 2006 Jun 01; 14(11):3785-92. PubMed ID: 16460953
    [Abstract] [Full Text] [Related]

  • 2. Beta-diketo acid pharmacophore hypothesis. 1. Discovery of a novel class of HIV-1 integrase inhibitors.
    Dayam R, Sanchez T, Clement O, Shoemaker R, Sei S, Neamati N.
    J Med Chem; 2005 Jan 13; 48(1):111-20. PubMed ID: 15634005
    [Abstract] [Full Text] [Related]

  • 3. Depsides and depsidones as inhibitors of HIV-1 integrase: discovery of novel inhibitors through 3D database searching.
    Neamati N, Hong H, Mazumder A, Wang S, Sunder S, Nicklaus MC, Milne GW, Proksa B, Pommier Y.
    J Med Chem; 1997 Mar 14; 40(6):942-51. PubMed ID: 9083483
    [Abstract] [Full Text] [Related]

  • 4. Discovery of HIV-1 integrase inhibitors by pharmacophore searching.
    Hong H, Neamati N, Wang S, Nicklaus MC, Mazumder A, Zhao H, Burke TR, Pommier Y, Milne GW.
    J Med Chem; 1997 Mar 14; 40(6):930-6. PubMed ID: 9083481
    [Abstract] [Full Text] [Related]

  • 5. Discovery and structure-activity relationship studies of a unique class of HIV-1 integrase inhibitors.
    Dayam R, Sanchez T, Neamati N.
    ChemMedChem; 2006 Feb 14; 1(2):238-44. PubMed ID: 16892356
    [Abstract] [Full Text] [Related]

  • 6. Design and optimization of tricyclic phtalimide analogues as novel inhibitors of HIV-1 integrase.
    Verschueren WG, Dierynck I, Amssoms KI, Hu L, Boonants PM, Pille GM, Daeyaert FF, Hertogs K, Surleraux DL, Wigerinck PB.
    J Med Chem; 2005 Mar 24; 48(6):1930-40. PubMed ID: 15771437
    [Abstract] [Full Text] [Related]

  • 7. A platform for designing HIV integrase inhibitors. Part 2: a two-metal binding model as a potential mechanism of HIV integrase inhibitors.
    Kawasuji T, Fuji M, Yoshinaga T, Sato A, Fujiwara T, Kiyama R.
    Bioorg Med Chem; 2006 Dec 15; 14(24):8420-9. PubMed ID: 17005407
    [Abstract] [Full Text] [Related]

  • 8. Discovery of structurally diverse HIV-1 integrase inhibitors based on a chalcone pharmacophore.
    Deng J, Sanchez T, Al-Mawsawi LQ, Dayam R, Yunes RA, Garofalo A, Bolger MB, Neamati N.
    Bioorg Med Chem; 2007 Jul 15; 15(14):4985-5002. PubMed ID: 17502148
    [Abstract] [Full Text] [Related]

  • 9. Dissecting Tn5 transposition using HIV-1 integrase diketoacid inhibitors.
    Czyz A, Stillmock KA, Hazuda DJ, Reznikoff WS.
    Biochemistry; 2007 Sep 25; 46(38):10776-89. PubMed ID: 17725323
    [Abstract] [Full Text] [Related]

  • 10. Salicylhydrazine-containing inhibitors of HIV-1 integrase: implication for a selective chelation in the integrase active site.
    Neamati N, Hong H, Owen JM, Sunder S, Winslow HE, Christensen JL, Zhao H, Burke TR, Milne GW, Pommier Y.
    J Med Chem; 1998 Aug 13; 41(17):3202-9. PubMed ID: 9703465
    [Abstract] [Full Text] [Related]

  • 11. Diketo acid pharmacophore. 2. Discovery of structurally diverse inhibitors of HIV-1 integrase.
    Dayam R, Sanchez T, Neamati N.
    J Med Chem; 2005 Dec 15; 48(25):8009-15. PubMed ID: 16335925
    [Abstract] [Full Text] [Related]

  • 12. A platform for designing HIV integrase inhibitors. Part 1: 2-hydroxy-3-heteroaryl acrylic acid derivatives as novel HIV integrase inhibitor and modeling of hydrophilic and hydrophobic pharmacophores.
    Kawasuji T, Yoshinaga T, Sato A, Yodo M, Fujiwara T, Kiyama R.
    Bioorg Med Chem; 2006 Dec 15; 14(24):8430-45. PubMed ID: 17010623
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Naphthoxazepine inhibitors of HIV-1 integrase: synthesis and biological evaluation.
    Garofalo A, Grande F, Brizzi A, Aiello F, Dayam R, Neamati N.
    ChemMedChem; 2008 Jun 15; 3(6):986-90. PubMed ID: 18383063
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Chemistry and structure-activity relationship of HIV-1 integrase inhibitor integracide B and related natural products.
    Singh SB, Ondeyka JG, Schleif WA, Felock P, Hazuda DJ.
    J Nat Prod; 2003 Oct 15; 66(10):1338-44. PubMed ID: 14575434
    [Abstract] [Full Text] [Related]

  • 18. Design, synthesis, and anti-integrase activity of catechol-DKA hybrids.
    Maurin C, Bailly F, Mbemba G, Mouscadet JF, Cotelle P.
    Bioorg Med Chem; 2006 May 01; 14(9):2978-84. PubMed ID: 16412645
    [Abstract] [Full Text] [Related]

  • 19. HIV integrase as a target for antiviral chemotherapy.
    Nair V.
    Rev Med Virol; 2002 May 01; 12(3):179-93. PubMed ID: 11987143
    [Abstract] [Full Text] [Related]

  • 20. Structure-activity relationships: analogues of the dicaffeoylquinic and dicaffeoyltartaric acids as potent inhibitors of human immunodeficiency virus type 1 integrase and replication.
    King PJ, Ma G, Miao W, Jia Q, McDougall BR, Reinecke MG, Cornell C, Kuan J, Kim TR, Robinson WE.
    J Med Chem; 1999 Feb 11; 42(3):497-509. PubMed ID: 9986720
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.